TVTX 241220 20.00C (TVTX241220C20000) Stock Options, News & Quotes

US OptionsDetailed Quotes

TVTX241220C20000

Watchlist

0.63
-0.02-3.08%

15min DelayClose Nov 22 16:00 ET

0.63High0.63Low

Intraday

5D
Daily

News

Travere Therapeutics (TVTX) Gets a Buy From J.P. Morgan
TipRanksNov 21 07:05 ET · Ratings
Express News | Travere Therapeutics Inc : JP Morgan Cuts Target Price to $42 From $43
ReutersNov 20 00:28 ET
JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Seeking AlphaNov 19 11:06 ET
Travere Therapeutics Is Maintained at Neutral by Piper Sandler
Dow JonesNov 14 09:28 ET · Ratings
Piper Sandler Maintains Travere Therapeutic(TVTX.US) With Hold Rating, Raises Target Price to $22
Moomoo NewsNov 14 07:34 ET · Ratings
Piper Sandler Reaffirms Their Hold Rating on Travere Therapeutics (TVTX)
TipRanksNov 14 07:16 ET · Ratings

Comments

Jaguar8

Nov 4 13:02

NEWS 13G

$Travere Therapeutic (TVTX.US)$
Travere Therapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.02%)

Stock_Drift

Oct 26 08:40

Earnings on 10/31 👻🎃

$Travere Therapeutic (TVTX.US)$

MMu

Oct 17 13:03

$Travere Therapeutic (TVTX.US)$ They got the europe approval as well! When is the next event date? @anyone

MMu

Oct 14 14:06

$Travere Therapeutic (TVTX.US)$
Someone buying large blocks 150k, 50k....
Does anybody know what's going on?

Jaguar8

Sep 26 15:03

NEWS

$Travere Therapeutic (TVTX.US)$
Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up
SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced a voluntary pause of enrollment in the Phase 3 HARMONY Study evaluating pegtibatinase for the treatment of classical homocystinuria (HCU). The voluntary enrollment pause enables the Company to work to address ...